missing translation for 'onlineSavingsMsg'
Learn More

Merck™ Novagen™ Origami™ B (DE3) Competent Cells

Origami B host strains carry the same mutations as the original Origami strain, except that they are derived from a lacZY mutant of BL21 to enable precise control of expression levels using IPTG.

Marca:  Merck™ 70837-4

Detalles adicionales : Peso : 0.01000kg

 Ver más versiones de este producto

Código de producto. 15559050

  • 378.72€ / 1 ml


Fecha estimada de envío
11-12-2018
Añadir a la cesta

Descripción

Descripción

Origami™ B host strains carry the same mutations in trxB and gor as the original Origami strains, except that they are derived from a lacZY mutant of BL21 to enable precise control of expression levels by adjusting the concentration of IPTG. Thus the Origami B strains combine the desirable characteristics of BL21, Tuner™, and Origami strains in one strain background. The mutations in trxB and gor are selectable on kanamycin and tetracycline, respectively; therefore, these strains cannot be used with plasmids that can only selected with kanamycin or tetracycline. These strains also include the lon and ompT deficiences of BL21, which increase protein stability. DE3 indicates that the host is a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene under control of the lacUV5 promoter. Such strains are suitable for production of protein from target genes cloned in pET vectors by induction with IPTG.
Especificaciones

Especificaciones

Guaranteed efficiency: >2 x 106 cfu/μg
1mL
Store at ≤-70deg.C
Videos